An article in a recent issue of The American Journal of Medicine by Chang et al1 indicated high risks of major bleeding in prescribing anticoagulants in patients with atrial fibrillation and stage 4 or 5 chronic kidney disease.1 Though the study is professional in general, there are some critical methodological issues requiring further discussion.
Ignored Biases in the Study of Oral Anticoagulants in Patients With Atrial Fibrillation and Stage 4 or 5 Chronic Kidney Disease
Related Posts
Order Antibiotics online
June 8, 2024Buying antibiotics online
June 8, 2024How do antibiotics work?
June 8, 2024Flagyl: a beacon of hope in the fight against trichomoniasis
February 17, 2024
About admin
Now Dr. Jack Straw is in charge of the website, and organizes it so that medical care is available to everyone. In addition, he is an active member of the medical community, regularly attending international conferences and sharing his experience and knowledge.
Dr. Straw is not only a medical professional and website manager, but also a loving husband and father of his beautiful children.
View all posts by admin →